More tools:Markets·Screener·Research·Chat

Cellectis S.A. American Depositary Shares (CLLS) Financial Statements

Cellectis S.A. American Depositary Shares
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG0084L1YD1
XNAS · usd
3.16▼ 0.08 (-2.47%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA—
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA—
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close3.24
Day's Range3.12 – 3.23
52-Week Range2.35 – 5.48
Volume37.5K
Avg Volume17.5K
Share Statistics
Shares Outstanding
Employees229
ExchangeXNAS
Listed2015-03-25
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Cellectis S.A. American Depositary Shares (CLLS)
What is Cellectis S.A. American Depositary Shares's Market Cap?
Cellectis S.A. American Depositary Shares's Market Cap is $317.1M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Enterprise Value?
Cellectis S.A. American Depositary Shares's Enterprise Value is $255.5M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Price / Sales?
Cellectis S.A. American Depositary Shares's Price / Sales is 4.3×, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's EV / Revenue?
Cellectis S.A. American Depositary Shares's EV / Revenue is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Revenue (TTM)?
Cellectis S.A. American Depositary Shares's Revenue (TTM) is $72.9M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Net Income (TTM)?
Cellectis S.A. American Depositary Shares's Net Income (TTM) is -$67.6M, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Diluted EPS (TTM)?
Cellectis S.A. American Depositary Shares's Diluted EPS (TTM) is -0.67, based on as-reported figures from SEC (XBRL) filings.
What is Cellectis S.A. American Depositary Shares's Net Debt?
Cellectis S.A. American Depositary Shares's Net Debt is -$61.5M, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Profit or loss [abstract]
Revenues
Other income
Total revenues and other income
Operating expenses
Cost of revenue
Research and development expenses
Selling, general and administrative expenses
Other operating income (expenses)
Total operating expenses and other operating income
Operating income (loss)
Financial income
Financial expenses
Tax income (expense)
Income (loss) from continuing operations
Income (loss) from discontinued operations
Net income (loss)
Attributable to shareholders of Cellectis
Attributable to non-controlling interests
Basic / Diluted net income (loss) per share attributable to shareholders of Cellectis
Basic net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Diluted net income (loss) attributable to shareholders of Cellectis, per share ($ /share)
Basic net income (loss) attributable to shareholders of Cellectis from discontinued operations, per share ($ /share)
Diluted net income (loss) attributable to shareholders of Cellectis from discontinued operations, per share ($ /share)